Outcomes in ovarian Sertoli-Leydig cell tumor: A report from the International Pleuropulmonary Blastoma/DICER1 and Ovarian and Testicular Stromal Tumor Registries
CONCLUSION: Most individuals with SLCT fare well, though specific risk factors such as mesenchymal heterologous elements are associated with poor prognosis. We also highlight the role of DICER1 surveillance in early detection of SLCT, facilitating stage IA resection.PMID:38657450 | DOI:10.1016/j.ygyno.2024.04.005
Source: Gynecologic Oncology - Category: Cancer & Oncology Authors: Alexander T Nelson Anne K Harris Dave Watson Junne Kamihara Kenneth S Chen Jennifer N Stall Kyle M Devins Robert H Young Damon R Olson Paige H R Mallinger Sarah G Mitchell Lindsey M Hoffman Gail Halliday Amina M Suleymanova Julia L Glade Bender Yoav H Mes Source Type: research
More News: Cancer & Oncology | Chemotherapy | Leydig Cell Tumor | Ovaries | Pathology | Pleuropulmonary Blastoma | Sertoli-Leydig Cell Tumor